Endoscopy 2025; 57(S 02): S161
DOI: 10.1055/s-0045-1805410
Abstracts | ESGE Days 2025
Oral presentation
Upper GI endoscopy – A Deep Dive 05/04/2025, 10:30 – 11:30 Room 124+125

Organisational factors and Post Endoscopy Upper Gastrointestinal Cancer (PEUGIC): results of the English national PEUGIC project

A Srinivasa
1   Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom
,
R Fiadeiro
2   Health Data Insight CIC, Fulbourn, United Kingdom
,
T Rahman
2   Health Data Insight CIC, Fulbourn, United Kingdom
,
K Clements
2   Health Data Insight CIC, Fulbourn, United Kingdom
,
N Burr
3   The Mid-Yorkshire Hospitals NHS Trust, Wakefield, United Kingdom
,
M Banks
4   University College London Hospitals Nhs Foundation Trust, London, United Kingdom
,
A Dhar
5   County Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom, Darlington, United Kingdom
,
C Healey
6   Airedale General Hospital, Steeton, United Kingdom
,
M Mccord
7   Heartburn cancer UK, Hampshire, United Kingdom
,
S Goel
2   Health Data Insight CIC, Fulbourn, United Kingdom
,
T Gentry
2   Health Data Insight CIC, Fulbourn, United Kingdom
,
D Mukherjee
8   Barking, Havering And Redbridge University Hospitals Nhs Trust, Romford, United Kingdom
,
W Chapman
9   Sandwell General Hospital, Sandwich, United Kingdom
,
M Thronton
10   University Hospital Wishaw, Wishaw, United Kingdom
,
I Maine
11   Belfast Health ' Social Care Trust, Belfast, United Kingdom
,
J Green
12   Cardiff and Vale University Health Board, Cardiff, United Kingdom
,
B Kluettgens
13   British Society of Gastroenterology, London, United Kingdom
,
N Husbands
13   British Society of Gastroenterology, London, United Kingdom
,
R Valori
14   Cheltenham General Hospital, Cheltenham, UK, United Kingdom
,
N Trudgill
15   Sandwell General Hospital, Sandwell, United Kingdom
› Author Affiliations
 

Aims Post endoscopy upper gastrointestinal cancers (PEUGIC) are often missed opportunities to diagnose earlier or even prevent cancer. A national process for identifying all PEUGIC in the English National Health Service and performing root cause analysis was developed. In parallel, a survey of diagnostic and surveillance upper gastrointestinal endoscopy practices was undertaken to investigate organisational factors which may contribute to variations in endoscopy quality and PEUGIC.

Methods PEUGIC occurring 3-36 months after an index endoscopy without a cancer diagnosis between 2017 and 2023 were identified from National Cancer Registration and Hospital Episode Statistics Datasets. Data from local root cause analysis were uploaded onto a secure portal for national analysis. Endoscopy providers taking part in the project were asked to complete an online organisational survey, covering diagnostic and surveillance endoscopic practices, equipment, the management of dysplasia and early cancer.

Results 3151 PEUGIC were examined by local reviewers in 144 hospitals in England. 635 were excluded. Data were available for 2516 PEUGIC. 1897 PEUGIC (75.4%) were following diagnostic endoscopy and 618 (24.6%) were undergoing surveillance. 80% of hospitals responded to the organisational survey. Hospitals with no guidelines for diagnostic endoscopy were associated with PEUGIC resulting in harm OR 1.50 (95% CI 1.23-1.84). For diagnostic PEUGIC, less than 20 minutes allocated to endoscopy were associated with no abnormalities detected in the PEUGIC segment OR 1.25 (95% CI 1.04-1.50). Oesophageal squamous cell PEUGIC were also associated with less time allocated per endoscopy OR 1.28 (95% CI 1.03-1.59) [1]. For surveillance PEUGIC, organisational factors associated with increased detection of stage 1 (success of surveillance) PEUGIC compared with stage 2 or greater were: dedicated surveillance sessions OR 2.08 (95% CI 1.46-2.98),>20 minutes for endoscopy OR 2.05 (95% CI 1.48-2.84), surveillance in an endoscopic resection centre OR 3.50 (95% CI 1.99-6.13) and guidelines for surveillance endoscopy OR 1.86 (95% CI 1.35-2.55). Booking delays and errors were noted in 12% of PEUGIC, patient factors were noted in 11% and poor clinical decision making in 11.7% (inappropriate or not acted upon decision 7.5% and histology not actioned in 4.2%). Surveillance was delayed in 27% of PEUGIC and this was associated with adverse treatment outcomes OR 1.79 (95% CI 1.72-2.73).

Conclusions A survey of endoscopy providers’ organisational structure has revealed a number of factors which contribute to PEUGIC not captured during individual root cause analysis. Hospitals that have local endoscopy guidelines perform better than those without. Surveillance outcomes are better in patients that have their endoscopies in dedicated surveillance sessions, with more time allocated and undertaken in endoscopic resection centres. However, surveillance delays are common and associated with worse outcomes



Publication History

Article published online:
27 March 2025

© 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Kamran U, King D, Abbasi A, Coupland B, Umar N, Chapman WC, Hebbar S, Trudgill NJ.. A root cause analysis system to establish the most plausible explanation for post-endoscopy upper gastrointestinal cancer. Endoscopy 2023; 55 (02): 109-118 Epub 2022 Aug 31. PMID: 36044914